The biosynthesis of fulvic acid, a fungal metabolite of heptaketide origin

The biosynthesis of fulvic acid, a fungal metabolite of heptaketide origin

Tetrahedron Letters Vol. 27, pp 493 - 496 @Pergamon Press Ltd. 1981. Printed in Great Britain 0040-4039/f31/0201-0493$02.00/O THE BIOSYNTHESIS OF FU...

264KB Sizes 0 Downloads 19 Views

Tetrahedron Letters Vol. 27, pp 493 - 496 @Pergamon Press Ltd. 1981. Printed in Great Britain

0040-4039/f31/0201-0493$02.00/O

THE BIOSYNTHESIS OF FULVIC ACID, A FUNGAL METABOLITE OF HEPTAKETIDE ORIGIN Itsuo Kurobane and C. Richard Hutchinson* School of Pharmacy, University of Wisconsin, Madison, WI 53705, U.S.A. and Leo C. Vining Department of BioZogy, Ddhousie University, HaZifax, Nova Scotia, B3H 4J1, Canada Swmary: Analyses of the regiochemistryof [13C]acetate incorporation into fulvic acid (2) by PeniciZtiwn brefetdirmwn indicates that the metabolite is biosynthesized via a heptaketid; intermediate assembled as a single chain of seven C units rather than from two smaller polyketide chains. This information favours a route le0ding through comnon Cl4 intermediates to the three fungal metabolites, citromycetin, fulvic acid and fusarubin. Within the large class of fungal metabolites of polyketide origin, those formed from seven C2 units have been subdivided by Turner,' on the basis of structure and available biosynthetic information, into eight groups. Compounds in the first seven are logically derived from a comnon linear heptaketide intermediatewhich is made from one acetyl and six malonyl units. The different groups of end-products are postulated to arise from folding pattern variations during subsequent cyclizing reactions. Citromycetin (1) and fulvic acid (_2),the two compounds in Turner's eighth group, were distinguished from the heptaketide-basedmetabolites in that their structures could not be derived by simple linear chain folding. Birch and co-workers' showed that seven C2 units originating from [14C]acetatewere incorporated into 1 by &nicitliwn frequentans. Later, Gatenbeck and Mosbach3 found evidence for two starter units by chemical degradation of 1 labeled biosyntheticallyfrom diethyl [2-'4C]malonate and concluded that two polyketide chains contributed to the structure. A 13C NMR study of 1 labeled from [l-13C),[2-'3C]-and [1,2-13Clacetate showed a labelling pattern consistent with a two-chain origin4 but also did not exclude pathways in which a single chain is cyclized and then ring-opened to a branched intermediate such as has been postulated on several occasions5'6 to be the progenitor of 1, ,2and fusarubin (2). Two such pathways have been noted, one involving a palitantin-type'and the other a fusarubin-type'folding of the heptaketide. We are persuaded by evidence presented here for the biosynthesis heptaketide

that 1, ,2 and 3 arise from common

ketide folding

pattern

route to the 4a,lOa-dihydrofusarubins, idea has recently

been validated

Oxidative

of the indicated

fission

C,4 intermediates

(A) that gives B upon intramolecular

as shown in Fig. 1.

aldol cyclization

from which 3 is formed by non-enzymic

by labeling

experiments

with

which

a direct

oxidation.8

This

acetate.'

bond in B, followed by appropriate bond reconnections (shown

of all fungal metabolites

single linear heptaketide

The hepta-

provides

[13C]- and C2H1-labeled

later in Scheme 1) would give rise to 1 and ,2. The hypothesis for the biogenesis

of ,2 via a single-chain

is modified

containing

is attractive

because

seven C2 units as derivatives

by organism-specific

cyclizing

it accounts of a

and processing

reactions. PeniciZZizun brefeldianwn Raulin-Thom

medium.lO*ll

Dodge (NRRL 2083) produces ,2 and palitantin

Both products reach their maximum 493

yield

(_4) when grown

in

on day 5 of the fermentation.

494

citromycetin(!)

Figure

Probable

3.

Experiments precursor

with

biogenetic

fulvic acid(?I

fusarubin(3)

origin of citromycetin,

[l- 14C]acetate

fulvic acid and fusarubin.

showed that 14C enrichment

of ,2 was highest

(18-19%)

if the

was fed on days 2 and 3 whereas _4 was maximally enriched by precursor feeding on days 13 To achieve high C incorporation, therefore, we administered [l-13C]acetate and

3 and 4.

[1,2-'3C2]acetate the two-day

(each containing

periods

of maximum

90 atom % l3 C) to give 5 rnfjbroth concentrations

metabolite

The labeled

production.

products were

twice during

isolated

on

day 5. The 6c relative were assigned pyridine

to internal

comparison

on the basis of:

and their respective

in the 13C NMR spectrum

Me4Si of all signals

trimethyl

of 6c val;;s

for ,2 and anhydrofulvic ,5 and _7,inchloroform;

derivatives,

of fulvic acid acid (5)" the $H

in

coupling

relationships in these four compounds observed by gated proton irradiation (NOE) experiments; 1 13 C NMR spectra of 13C-enriched ,5 and ,7. THE NOE &c coupling data obtained from the

and

spectrum

of 2 had two triplet signals

a high-field

quartet

and a mid-field

in the upfield doublet

region;

appeared

that of _6 had only one.

in the NOE spectrum

this evidence

we could assign the 6c of C-2, C-7, C-9 and C-11 securely.

ments enabled

us to use the unique

in the spectrum

of l3 C-enriched

l*c

The 6c of C-3a and C-4 were distinguished coupling

for C-3a but the absence

could assign constants upfield

with

C-3a and with C-4.

of long-range

also labeled

of [1,2-13C2]acetate

and

per site.

Its (+)

From these data we carbon

coupling

by its characteristic

in 2 vs. 5 and 6 vs. 7.

spectral

regiochemistry

into fulvic acid by analyzing

of 2.6+0.2%

for C-4.

of a 3&H

of C-5 and of C-6 was based on the relative

6c values

The pertinent

the complete

assign-

intact C2 units

and by the presence

the value of their respective

data areshown

([1-13C]Acetate

in Figure 2.

of the incorporation of [1-13C]acetate and 13 C NMR spectra of 13C enriched 2, 7; $, the

Fulvic acid was labeled only at the (0) carbons

enrichment

for all seven

The 6c for C-12 is also defined

patterns

of 2 and ,5. From The resulting

shifts of C-2a, C-7a, C-8a and C-10.

of any long range C,H coupling

Finally assignment

C-5 and not C-6.)

We then determined

and 7.

+H

visible

by the value of 'J -C4C12

the 6c of C-3 and C-12 by noting

shift on methylation.

magnitudes

relationships

,7 to assign the chemical

Similarly,

(Fig. 2) by [l-13C]acetate

carbon pairs were labeled

with a

by [l,E-13C]acetate

C

495

Figure 2.

13C NMR data for fulvic acid and its derivatives. J values shown for 5 and ,7are +1.2 Hz and all spectra were determined at 22.5 MHz-!?t27°C.

(Fig. 2) with a l3C enrichment of 1.&0.2% per site. Since we could clearly see the small quartet resonances due to '%C

coupling between carbons in neighboring 13C2 sub-sets for at

least one carbon of each C2 unit in the 13C NMR spectrum of 5, we could calculate that the 13C enrichment of the individual acetyl/malonyl units was 45+2% at the time of polyketide chain 9 assembly. The manner in which fulvic acid is labelled by [13C]acetate is compatible with its formation from a single heptaketide chain folded as in A (Fig. 1), which is then cyclized and ringopened without C2-unit bond fission as in the biosynthesis of citromycetin. The nearly equal enrichment by

["Clacetate of all one- and two-carbon subsets and the consistent high 13C

enrichment of all seven C2 subsets at the time of chain assembly are more likely for a singlechain origin than for one in which separately formed chains come together. In particular, the intermolecularenrichment of two polyketide chains would probably have fallen below the observed 45% due to dilution with unlabeled material before fusion occurred; we should not then have observed coupling between the neighboring carbons of C2 units joined in the fusion process. Finally, we can discount palitantin as a precursor of fulvic acid in P. brefeZdianm 12 because ,2was enriched by acetate significantly earlier than 4. The weight of evidence from this study and that on fusarubin' thus favours the conclusion 13 Scheme 1 shows a reasonable sequence that 1, 2 and ,3have a common biosynthetic parentage. of biochemical transformationsby which these metabolites could be formed from intermediateB 14 of Fig. 1.

496

Scheme 1.

Biogenetic hypothesis for the formation of citromycetin fusarubin (2) from a comnon intermediate @).

(I), fulvic acid (_2) and

References and Notes

(1) (2)

Turner,

W.B.,

Birch, A.J., 1958, 4576. WI__

(3) Gatenbeck,

"Fungal Metabolites",

Academic

Press,

Fitton, P., Pride, E., Ryan, A.J.,

S. and Mosbach,

(4) Evans, G.E. and Staunton,

K., Biochem. J., J.C.S.

Biophys.

London,

H.B., J. Chem. Sot.,

Res. Cornnun., ."__... 1963, 11, 166.

Chem. Comm., _..,__ 1976, 760.

(5) Birch, A.J., Fortschr. Chem. Org. Naturstoffe, 1957, 14, 1_9_5_8, 131; Thomas, R., Biochem. J., MY, 7& 748. (6) Dean, F.M., Eade, R.A., Moubasher,

1971, pp. 140-156.

Smith, H. and Whalley,

R.A. and Robertson,

186; Whalley,

A., ) Nature

W.B.,

1957 ____'

-’179

Chem. and Ind. 366.

(7) Whalley, W.B., in 'Recent Developments in the Chemistry of Natural Phenolic Compounds' ed. W.D. Ollis, Pergamon Press, Oxford, 1961, p. 49; Money, T., Nature, 1_9_6_3, 199, 592; Stickings, C.E. and Mahmoudian, A., Chem. and Ind., -WI-_ 1962, 1718. (8) Kurobane,

I., Vining,

L.C., McInnes,

A.G. and Smith,

(9) Kurobane,

I., Vining,

L.C., McInnes,

A.G. and Walter,

(10) Dean, F.M., Eade, R.A., Moubasher, (11) F

Czapek-Dox

medium

the fungus

D.G., Can. J. Chem., _I__ 1978, 56, 1593.

R.A. and Robertson,

is variously

reported

J.A.,

Can. J. Chem.,

1980, 3, ..,_-_

1380.

A., J. Chem. Sot., _I__ 1957, 3497. to produce only brefeldin

A (Harri,

1963, 46, 1235) ., Loeffler, W., Sigg, H.P., Stahelin, H. and Tamn, Ch., Helv. Chim. Acta, _I-._

or chiefly

griseofulvin

(ref. 6 above).

(12) We determined the regiochemistry of 4 labeled from [13C]acetate and found it to be as previously reported for [14C]acetate-'(Birch, A.J. and Cocor, M., J. Chem. Sot., __-I 1960, 866; Chaplen, P. and Thomas, R., Biochem. J., __I_ 1960, 77, 91). (13) Although the results cited in ref. 3 do not support this conclusion we do not wish to cormnent until the biosynthesis of 1 is reexamined with appropriate 13C-labeled precursors. (14) This research was supported in part by a grant (GM 25799) from the National Institutes of Health, by a Research Career Award to C.R.H. (CA 00257) for 1976-81 and by an operating grant from the Natural Sciences and Engineering Research Council of Canada. (Received

in USA 14 October

1980)